Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed May 13, 2022
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2022-05-12$14.58/sh+36$525→ 1,239,651 total - Purchase
Common Stock
2022-05-12$15.85/sh+1,184$18,766→ 1,240,835 total - Purchase
Common Stock
2022-05-12$16.61/sh+58$963→ 1,240,893 total
Footnotes (4)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.35 to $14.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.
- [F3]Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.45 to $16.45. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F4]Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.46 to $17.46. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.